Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Nature Medicine
|
May 31, 2025
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial
Tina Cascone, Laura Bonanno, Florian Guisier, et al.
Oncoimmunology
|
January 18, 2021
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study
Fabrice Barlesi, Adrien Dixmier, Didier Debieuvre, et al.
The European Respiratory Journal
|
February 6, 2025
Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networks
Romy Ratsihorimanana, Thomas Maitre, Matthieu Dusselier, et al.
Respirology (Carlton, Vic.)
|
April 18, 2024
Therapeutic bronchoscopy for malignant central airway obstructions caused by non-bronchogenic cancers: Results from the EpiGETIF registry
Clément Daigmorte, Daniela Usturoi, Clément Fournier, et al.
Respiration; International Review of Thoracic Diseases
|
April 6, 2025
Predictive Factors of Clinical Success of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction: Results from the EpiGETIF Registry
Pascalin Roy, Lyria Amari, Sophie Laroumagne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2026
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial
Thomas Pierre Walter, Julien Mazieres, Josiane Otto, et al.
Respirology (Carlton, Vic.)
|
March 4, 2024
Therapeutic bronchoscopy for malignant central airway obstruction: Introduction to the EpiGETIF registry
Nicolas Guibert, Pascalin Roy, Lyria Amari, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Nature Medicine
|
May 31, 2025
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial
Tina Cascone, Laura Bonanno, Florian Guisier, et al.
Oncoimmunology
|
January 18, 2021
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study
Fabrice Barlesi, Adrien Dixmier, Didier Debieuvre, et al.
The European Respiratory Journal
|
February 6, 2025
Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networks
Romy Ratsihorimanana, Thomas Maitre, Matthieu Dusselier, et al.
Respirology (Carlton, Vic.)
|
April 18, 2024
Therapeutic bronchoscopy for malignant central airway obstructions caused by non-bronchogenic cancers: Results from the EpiGETIF registry
Clément Daigmorte, Daniela Usturoi, Clément Fournier, et al.
Respiration; International Review of Thoracic Diseases
|
April 6, 2025
Predictive Factors of Clinical Success of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction: Results from the EpiGETIF Registry
Pascalin Roy, Lyria Amari, Sophie Laroumagne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2026
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial
Thomas Pierre Walter, Julien Mazieres, Josiane Otto, et al.
Respirology (Carlton, Vic.)
|
March 4, 2024
Therapeutic bronchoscopy for malignant central airway obstruction: Introduction to the EpiGETIF registry
Nicolas Guibert, Pascalin Roy, Lyria Amari, et al.
Page
of 3